In the past five years, the School has been intentional about creating an environment that rewards risk-taking and supports failures. It’s led to story slams and accelerators and a shift to an innovation-centric mindset.
A coordinated campus testing plan for COVID-19 that relies on saliva-based tests had its soft launch in early December. The large-scale COVID-19 screening program known as Project Quaker will allow COVID-19 to be tracked and mitigated at Penn and is an essential component for plans to bring students back to campus safely for the spring semester.
As opioid overdoses continue to grab headlines, more states are providing their communities with easier access to naloxone, which can prevent death by reversing opioid overdoses. But while naloxone may be available at township buildings, libraries, or other community locations, little is known about how schools maintain a supply and use naloxone to prepare for treating overdose.
The University of Pennsylvania School of Nursing’s Center for Global Women’s Health and national maternal health experts from nursing, midwifery, medicine, public health, policy, and advocacy held a virtual conference to explore multilevel approaches to reducing maternal morbidity and mortality in the United States. Access the April 29, 2021 recording here.
Social media and web-based news channels became a communication superhighway for correct and incorrect public health information during the COVID-19 pandemic. The study of this vast amount of information, known as infodemiology, is critical to building public health interventions to combat misinformation and help individuals, groups, and communities navigate and distill crucial public health messages.
More than 90 percent of human papillomavirus (HPV)-related cancers could be prevented by widespread uptake of the HPV vaccine. Yet, vaccine use in the United States falls short of public health goals.
On November 18, 2020, Xi Chapter welcomed undergraduate, graduate, and community inductees in our Chapter.
Type 1 diabetes (T1D) is the third most common pediatric chronic disease in the United States, and the risk of the disease has risen sharply in non-Hispanic Black (NHB) children in the last 20 years, data show. Ironically, the significant advances in T1D therapeutics over recent years, especially new technologies, may have exacerbated racial disparities in diabetes treatment and outcomes.
Insulin pumps are widely used in the management of type 1 diabetes (T1D) and reviews have shown insulin pump therapy to be associated with improved glycemic control, fewer severe hypoglycemia events, and improved quality of life. Yet, non-Hispanic white children (NHW) are more than twice as likely as non-Hispanic Black children (NHB) to use this technology.
The diverse situations experienced by health-care workers during the COVID-19 pandemic often present serious ethical challenges. From the allocation of resources and triage protocols to health-care worker and patient rights and the management of clinical trials, new ethical questions have come to the forefront of today’s global public health emergency.